Trials / Conditions / Bone Metastases in Subjects With Advanced Breast Cancer
Bone Metastases in Subjects With Advanced Breast Cancer
4 registered clinical trials studyying Bone Metastases in Subjects With Advanced Breast Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer NCT01419717 | Amgen | Phase 3 |
| Completed | Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only NCT00950911 | Amgen | Phase 3 |
| Completed | Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonate NCT00104650 | Amgen | Phase 2 |
| Completed | Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer NCT00091832 | Amgen | Phase 2 |